ES2032628T3 - METHOD TO PRODUCE A SOLID PHARMACEUTICAL PREPARATION. - Google Patents

METHOD TO PRODUCE A SOLID PHARMACEUTICAL PREPARATION.

Info

Publication number
ES2032628T3
ES2032628T3 ES198989110019T ES89110019T ES2032628T3 ES 2032628 T3 ES2032628 T3 ES 2032628T3 ES 198989110019 T ES198989110019 T ES 198989110019T ES 89110019 T ES89110019 T ES 89110019T ES 2032628 T3 ES2032628 T3 ES 2032628T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
produce
preparation
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989110019T
Other languages
Spanish (es)
Inventor
Tadashi Makino
Koji Doi
Masayoshi Matsuoka
Toshiharu Tsuboi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2032628T3 publication Critical patent/ES2032628T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Provided are a solid pharmaceutical preparation which contains disodium adenosine triphosphate together with a vitamin B1 salt or the like and a method of treatment of human asthenopia by orally administering the same. Also provided are a solid pharmceutical preparation according to the abovementioned preparation, which further contains a low-melting fat- or oil-like substance and has an improved stability of disodium adenosine triphosphate, and a method of producing the same.
ES198989110019T 1988-06-03 1989-06-02 METHOD TO PRODUCE A SOLID PHARMACEUTICAL PREPARATION. Expired - Lifetime ES2032628T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63137925A JPH01308232A (en) 1988-06-03 1988-06-03 Solid drug and production thereof

Publications (1)

Publication Number Publication Date
ES2032628T3 true ES2032628T3 (en) 1993-02-16

Family

ID=15209888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989110019T Expired - Lifetime ES2032628T3 (en) 1988-06-03 1989-06-02 METHOD TO PRODUCE A SOLID PHARMACEUTICAL PREPARATION.

Country Status (8)

Country Link
US (1) US5017564A (en)
EP (1) EP0348688B1 (en)
JP (1) JPH01308232A (en)
KR (1) KR910000163A (en)
AT (1) ATE74768T1 (en)
DE (1) DE68901216D1 (en)
ES (1) ES2032628T3 (en)
GR (1) GR3004440T3 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634374B1 (en) * 1988-07-19 1993-10-15 Laboratoires Serobiologiques AGENTS Photoprotective, CYTOPHOTOPROTECTEURS SKIN WITH photoprotective activity CELL COMPONENTS, FUNCTIONAL SKIN, ESPECIALLY CELLS Langerhans, BASED COMPOUNDS NUCLEIC: NUCLEOPROTIDES, ribonucleotides and deoxyribonucleotides, ribonucleosides and deoxyribonucleosides, COSMETIC OR DERMO-PHARMACEUTICAL CONTAINING SUCH AGENT AS WELL AS NEW COMPOUNDS IN ITSELF
US5712258A (en) * 1995-03-23 1998-01-27 The Trustees Of The University Of Pennsylvania Inotropic ADP and ATP analogues and their pharmaceutical compositions
US7348315B2 (en) 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
WO2001028528A1 (en) * 1999-10-20 2001-04-26 Eliezer Rapaport Methods, pharmaceutical and therapeutic compositions for administering adenosine
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
JP2003119139A (en) * 2001-10-12 2003-04-23 Ss Pharmaceut Co Ltd Fatigue relieving pharmaceutical composition
US6585996B1 (en) 2002-03-13 2003-07-01 Westlake Laboratories, Inc. Lipid-soluble thiamine derivatives in the treatment of autism
US20050070701A1 (en) * 2003-09-29 2005-03-31 Hochstetler Spencer Erich Detection of living cells in polymers or pigments
ITMI20041772A1 (en) * 2004-09-17 2004-12-17 Bioprogress Spa CONTROLLED FORMULATION OF THIAMINE AND THEIR USE IN THE TREATMENT OF PATHOLOGIES LINKED TO DEFECTS IN THE LEARNING AND STORING PROCESSES.
JP5032310B2 (en) * 2005-05-27 2012-09-26 興和株式会社 Medicine for fatigue recovery
TW200812601A (en) * 2006-05-30 2008-03-16 Kowa Co Medicine for recovering from fatigue
WO2008001494A1 (en) * 2006-06-27 2008-01-03 Kowa Co., Ltd. Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue
EP3875092A4 (en) * 2018-11-02 2021-12-22 Kyungpook National University Industry-Academic Cooperation Foundation Composition for prevention or treatment of macular degeneration
EA202193041A1 (en) * 2019-05-06 2022-02-10 Феррер Интернасионал, С.А. MULTILAYER PHARMACEUTICAL OR NUTRICEUTIC SOLID DOSAGE FORMS CONTAINING PYRIMIDINE AND/OR PURINE DERIVATIVES AND VITAMINS B, THEIR PREPARATION AND APPLICATION

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2775521A (en) * 1953-09-29 1956-12-25 Hoffmann La Roche Method of fortifying grain products and the resulting product
US3037911A (en) * 1959-09-04 1962-06-05 Merck & Co Inc Chewable, palatable, vitamin b preparations
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
SE352811B (en) * 1971-06-04 1973-01-15 Pharmacia Ab
GB1431841A (en) * 1973-01-15 1976-04-14 Evans S C Ophthalmic-nutritional preparations
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
FR2358155A1 (en) * 1976-07-15 1978-02-10 Lapinet Eugene COMPOSITION FOR THE TREATMENT AND PREVENTION OF IRRITATION AND INFLAMMATION OF THE SKIN, EYE AND MUCOSAUSES
US4382924A (en) * 1980-06-25 1983-05-10 The Procter & Gamble Company Palatable composition containing oil or oil-like materials
FR2557452B1 (en) * 1983-12-28 1986-08-14 Roussel Uclaf NOVEL COMPOSITIONS FOR SKIN CARE CONTAINING PRIMER OIL AND RATE TISSUE TRAITS
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
US4764388A (en) * 1985-01-25 1988-08-16 Nabisco Brands, Inc. Method for making vitamin enriched cereal
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0816066B2 (en) * 1986-07-18 1996-02-21 エーザイ株式会社 Long-acting drug
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair

Also Published As

Publication number Publication date
EP0348688B1 (en) 1992-04-15
DE68901216D1 (en) 1992-05-21
GR3004440T3 (en) 1993-03-31
ATE74768T1 (en) 1992-05-15
US5017564A (en) 1991-05-21
KR910000163A (en) 1991-01-29
JPH01308232A (en) 1989-12-12
EP0348688A1 (en) 1990-01-03

Similar Documents

Publication Publication Date Title
ES2032628T3 (en) METHOD TO PRODUCE A SOLID PHARMACEUTICAL PREPARATION.
ATA195588A (en) EPIPODOPHYLLOTOXINGLUCOSIDE-4'-PHOSPHATE DERIVATIVES THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITIONS THEREOF
DE3575927D1 (en) PURINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION.
SE8602723D0 (en) THIAZOLES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK465181A (en) IMIDAZO (1,2-A) PYRIDINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
ES2084579T3 (en) USE OF BUSPIRONE IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOL ABUSE.
PT90030A (en) PROCESS FOR THE PREPARATION OF IFOSPHAMIDE AND MESNA LYOPHYLISATE
DK143588A (en) SUBSTITUTED 9-AMINO-TETRAHYDROACRIDINES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
IT8123602A0 (en) STABLE SALTS OF S-ADENOSYLMETHIONINE, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH INCLUDE THEM AS THE ACTIVE INGREDIENT.
LV10179A (en) Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and seedlings for their production
IT8123940A0 (en) DERIVATIVES OF S-ADENOSYLMETHIONINE, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT.
IT8123603A0 (en) STABLE SALTS OF S-ADENOSYLMETHIONINE, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH INCLUDE THEM AS THE ACTIVE INGREDIENT.
DK199789D0 (en) APPLICATION OF A PHENYLQUINOLINCARBOXYLIC ACID DERIVATIVE OR A PHARMACEUTICAL SUITABLE SALT THEREOF FOR THE PREPARATION OF A TOPICAL PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF SKIN AND / OR SLIMMETIC DISEASES
ES2054718T3 (en) THE USE OF GEPIRONE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATYPICAL DEPRESSION.
ES2054738T3 (en) DERIVATIVES OF 3-DESMETIL-4-FLUOROMEVALONIC ACID, PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS, THEIR USE AND INTERMEDIATE PRODUCTS.
IT8721691A0 (en) DERIVATIVES OF 1,2,5,6-TETRAHYDROPYRDIN-3-CARBOXALDEHYDE OXYME, THEIR PREPARATION PROCEDURE AND THEIR USE AS MEDICINAL SUBSTANCES.
ES2037095T3 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION.
MX8958A (en) PROCEDURE FOR OBTAINING A LYOPHILIZED PREPARATION CONTAINING IFOSFAMIDE.
IT8721687A0 (en) DERIVATIVES OF THE OXYME OF 1,2,5,6-TETRAHYDROPYRIDIN-3-CARBOXA LDEHYDE, THEIR PREPARATION PROCEDURE AND THEIR USE AS MEDICINAL SUBSTANCES.
ES2054188T3 (en) CHEWABLE OR CHUKABLE MEDICATION, PROCEDURE FOR ITS PRODUCTION AND APPLICATION.
NO950445L (en) Liponucleotides of seconucleosides, their preparation and their use as antiviral drugs
ES2043736T3 (en) 3,5-DIHYDROXY-HEPTANOIC ACIDS REPLACED WITH (1H-PIRROL-3-ILO) IN POSITION 7, ITS CORRESPONDING DELTA-LACTONES AND SALTS, PROCEDURES FOR THEIR PREPARATION, THEIR USE AS MEDICINES, PHARMACEUTICAL PREPARATIONS AND PRODUCTS.
IT8621526A0 (en) THEIR PREPARATION AND MEDICINES THAT CONTAIN THEM DERIVATIVES OF METHYLENDIOXYPHENTHRENE. AND STILBENE, PROCEDURE FOR THE
IE44461L (en) Piperazinyluracil salts
ES2039610T3 (en) DRUGS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 348688

Country of ref document: ES